SGI-1027
Kurzübersicht für SGI-1027 (ABIN7233289)
Applikation
Chemical Name
-
-
Verwendungszweck
- DNA methyltransferase inhibitor
-
Produktmerkmale
- Potent and selective inhibitor of DNA methyl transferase inhibiting DNMT1, DNMT3A and DNMT3B with comparable potency (IC50=12.5, 8.0 and 7.5 956M respectively). Treatment of various cancer cell lines with SGI-1027 results in selective degradation of DNMT1 (MG-132 sensitive) with minimal effect on DNMT3A and 3B at 2.5-5 μM. Prolonged treatment of RKO cells resulted in reexpression of silenced tumor suppressor genes. Synergizes with doxorubicin at growth inhibition in neuroblastoma cell lines. Disrupts the MKK3-MYC complex in cells and inhibits MYC transcriptional activity in colon and breast cancer cells.
-
Reinheit
- >98 %
-
Formel
- C27H23N7O
-
Löslichkeit
- Soluble in DMSO (35 mg/ml)
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Powder
-
Lagerung
- -20 °C
-
-
-
Hintergrund
- Epigenetics,Chromatin,DNA Methyltransferase,Prions,Cancer,Bcl,Myc
-
Molekulargewicht
- 461.5
-
CAS-Nummer
- 1020149-73-8
-
-